Extrahepatic Abdominal Surgery in Cirrhosis: EASL Clinical Practice Guidelines

Surgery in patients with cirrhosis is no longer viewed as uniformly prohibited, but it remains high-risk and must be approached in a structured way. The two most important determinants are the severity of liver disease and the type and urgency of surgery. A compensated patient with preserved liver function may tolerate elective surgery reasonably well, whereas a decompensated patient with significant portal hypertension may deteriorate rapidly after even a technically successful operation. For this reason, these guidelines strongly support multidisciplinary assessment involving hepatology, surgery, anaesthesia, radiology, nutrition, and critical care teams.

How Surgical Risk Should Be Assessed

The guideline makes it clear that risk assessment should not rely on clinical impression alone. A multimodal approach is preferred. The VOCAL-Penn score is currently the most useful modern surgical risk calculator and should be incorporated into practice. Traditional scores such as Child-Turcotte-Pugh and MELD still remain clinically relevant, especially because much of the existing literature still uses them.

Portal hypertension is a major issue because it strongly influences postoperative decompensation, bleeding, ascites, renal injury, and death. Non-invasive tests such as transient elastography and platelet count can help identify compensated advanced chronic liver disease and rule in or rule out clinically significant portal hypertension in selected patients. However, when surgical decision-making depends on accurate haemodynamic risk, hepatic venous pressure gradient (HVPG) remains the most informative tool. The guideline emphasizes that risk rises particularly when HVPG is above 16 mmHg and becomes especially concerning at 20 mmHg or more.

Risk According to Severity of Liver Disease

Patients with Child-Pugh A cirrhosis generally represent the group in whom elective surgery can be considered most safely, especially if portal hypertension is absent or limited and the operation can be performed laparoscopically in an experienced centre. This is the subgroup where the concept of “careful surgery after optimization” best applies.

Patients with Child-Pugh B cirrhosis fall into an intermediate but clearly increased risk category. Surgery is not automatically ruled out, but the threshold for proceeding should be higher. These patients require detailed assessment of portal hypertension, nutritional status, frailty, cardiopulmonary reserve, and operative necessity. In some selected patients, especially those with significant portal hypertension, preoperative strategies such as TIPS may be considered.

Patients with Child-Pugh C cirrhosis have very high perioperative mortality and morbidity. Elective extrahepatic abdominal surgery should generally be avoided in this group. If surgery is required, it is usually because of an emergency or life-saving indication, and even then, outcomes are poor.

The guideline is particularly cautious in patients with acute-on-chronic liver failure (ACLF). Once ACLF grade 2 or 3 is present, emergency surgery may often be futile unless the surgical pathology itself is reversible and the patient has a realistic path to recovery or transplantation.

Risk According to the Type of Surgery

Not all operations carry the same risk. The guideline supports thinking not just in terms of liver function, but also in terms of surgical stress.

Gallbladder surgery can be performed in selected cirrhotic patients, especially those with Child-Pugh A or B disease. Laparoscopic cholecystectomy is preferred over open surgery because it reduces complications and recovery time. In advanced disease, especially Child-Pugh C, non-surgical approaches such as percutaneous or endoscopic gallbladder drainage may be safer.

Hernia surgery is very relevant because umbilical and abdominal wall hernias are common in cirrhosis, particularly with ascites. The guideline supports elective repair in experienced centres after careful optimisation, because emergency surgery for incarceration or rupture carries much worse outcomes. In practical terms, elective repair is often safer than waiting for a crisis.

Colorectal surgery carries a substantially higher risk, especially because of infection, leakage, and decompensation. Emergency colorectal surgery is particularly dangerous. If surgery must be performed, minimally invasive approaches are preferred when feasible, and surgeons may need to consider diversion rather than primary anastomosis in high-risk patients.

Pancreatic surgery is one of the highest-risk operations in cirrhosis. The guideline allows consideration only in carefully selected Child-Pugh A patients without clinically significant portal hypertension, and only for malignancy or premalignant disease. It should be discouraged in Child-Pugh B or C patients, and it should not be done for benign pancreatic disease.

Aortic surgery, particularly for abdominal aortic aneurysm, may be considered in Child-Pugh A patients after careful assessment, but is discouraged in Child-Pugh B and C disease. Endovascular repair is preferred over open repair because it reduces physiological stress.

Emergency Surgery and the Concept of Futility

The guideline recognises that emergency surgery is often where the greatest uncertainty lies. In compensated cirrhosis, decisions may be made broadly in line with general surgical principles. However, in decompensated cirrhosis, especially with organ failures, a realistic discussion about futility becomes necessary. If surgery is unlikely to achieve the intended physiological goal, or if it may only prolong dying without meaningful recovery, proceeding may not be in the patient’s best interest. This is particularly relevant in advanced ACLF, severe sepsis, refractory shock, and profound physiological collapse.

Preoperative Optimization

The guideline places major emphasis on optimisation before any elective operation. The cause of liver disease should be treated whenever possible. This means strict alcohol abstinence in alcohol-related disease, antiviral therapy in viral cirrhosis, and broader metabolic treatment in MASLD where relevant.

Nutritional status should be assessed in all patients. Malnutrition, sarcopenia, and frailty are common in cirrhosis and meaningfully worsen outcomes. The guideline recommends prehabilitation, ideally starting 4 to 6 weeks before surgery, with physical conditioning, dietary intervention, and psychological preparation when possible.

Cardiopulmonary evaluation is also essential. A patient with cirrhosis may also have occult cardiac dysfunction, pulmonary hypertension, or hepatopulmonary syndrome. Electrocardiography, echocardiography, and pulse oximetry should be part of routine workup for major surgery.

Upper GI endoscopy is recommended in most patients unless clinically significant portal hypertension has already been excluded or appropriate variceal prophylaxis is already in place.

Role of TIPS Before Surgery

The guideline does not recommend routine preoperative TIPS for all cirrhotic patients with portal hypertension. In Child-Pugh A patients, evidence is not strong enough to support routine use. In selected Child-Pugh B or C patients with significant portal hypertension, however, preparatory TIPS may be considered by expert teams, particularly if the aim is to reduce postoperative ascites and portal hypertension-related complications. This remains an individualized decision rather than a standard rule.

Perioperative Bleeding and Coagulation

One of the most clinically useful messages from the guideline is that abnormal coagulation tests in cirrhosis should not automatically trigger correction. INR is not a reliable guide to true bleeding risk in these patients, and routine correction with plasma is not recommended. The haemostatic system in cirrhosis is rebalanced, and bleeding often relates more to portal hypertension or procedural injury than to simple clotting factor deficiency.

If active bleeding occurs, viscoelastic testing is preferred to guide transfusion. Platelets and fibrinogen may be corrected selectively in high-risk bleeding situations, but prophylactic transfusion based purely on standard laboratory values is discouraged.

Fluid Therapy and Haemodynamic Management

Fluid overload should be avoided. This is extremely important in cirrhosis because over-resuscitation worsens ascites, oedema, pulmonary congestion, and wound complications. Balanced crystalloids are generally preferred, and hydroxyethyl starch should be avoided because of kidney injury risk. The anaesthetic and critical care teams must maintain tissue perfusion while avoiding venous congestion and portal pressure excess.

Anaesthesia and Analgesia

Drug handling is altered in cirrhosis, so anaesthetic and analgesic doses must be adjusted according to hepatic function. Propofol is generally safe, and fentanyl is the preferred opioid because it lacks toxic metabolites and is less affected by hepatic dysfunction than longer-acting opioids. NSAIDs should be avoided because of renal risk and bleeding risk. Paracetamol remains safe in reduced doses, usually up to 2–3 grams daily. Benzodiazepines should be avoided in patients with encephalopathy.

Regional techniques may reduce systemic drug exposure, but nerve blocks and especially neuraxial techniques should be used cautiously in more advanced cirrhosis because of bleeding risk.

Enhanced Recovery and Postoperative Care

The guideline supports enhanced recovery after surgery (ERAS) principles in cirrhotic patients. These include structured perioperative nutrition, early mobilisation, careful analgesia, minimisation of unnecessary lines and drains, and early enteral feeding. Although data specific to cirrhosis are limited, the principles are strongly supported.

Postoperatively, patients require close monitoring for hepatic encephalopathy, ascites, jaundice, renal dysfunction, infection, and bleeding. The guideline suggests that intensive or high-dependency monitoring may be beneficial after major surgery, especially in high-risk patients, because deterioration can occur rapidly and early intervention matters.

Practical Clinical Take-Home

For a clinician, the most important way to remember this guideline is simple. A cirrhotic patient should never be judged for surgery based only on the label “cirrhosis.” The real questions are: How severe is the liver disease? Is clinically significant portal hypertension present? Is the surgery elective or emergency? Can it be done minimally invasively? Has the patient been optimised nutritionally and medically? And is the procedure being performed in a centre that truly understands cirrhosis?

In broad terms, Child-Pugh A patients may undergo selected elective surgery after proper assessment; Child-Pugh B patients require much greater caution and individualised planning; Child-Pugh C and ACLF patients are usually poor surgical candidates unless surgery is life-saving. Minimally invasive approaches are preferred wherever feasible, portal hypertension must be actively considered, and postoperative monitoring should be more vigilant than in non-cirrhotic patients.

If you want, I can next convert this into a one-page clinic table with columns for severity of cirrhosis, type of surgery, and practical recommendations